TAG:
cap
Insurers Dropping Medicare HMO Programs in Various Regions
Several of the nation’s largest health insurance companies will cease offering Medicare HMOs in certain regions of the United States. Almost 800,000 of the nature’s seniors will be dropped from Medicare +Choice plans as Aetna/US Healthcare, Foundation Health Systems, Oxford Health System…
Express Scripts, InformInvestor.com, UroCor, Bio-Reference Laboratories
PRESCRIPTION DRUG SPENDING HITS A RECORD INCREASE OF 17.4% IN 1999 Just-released data from Express Scripts, Inc. indicates that spending on prescription drugs increased by a record 17.4% during 1999. This compares to a 9.6% spending increase for drugs in 1998. As most lab e…
Investors Returning To Lab Industry
By R. Lewis Dark | From the Volume VII No. 9 – June 19, 2000 Issue
SOMETHING BIG IS HAPPENING to the clinical laboratory industry and the anatomic pathology profession. For the first time in six or seven years, the investment community is paying close attention to the laboratory industry. This should be a welcome development for commercial lab owners and anatomic …
Merger Creates “New” Pathology Competitor
By Robert Michel | From the Volume VII No. 9 – June 19, 2000 Issue
CEO SUMMARY: Pathology business consolidation and regionalization continues. Pathology Consultants of America, Inc. (PCA) and PathSOURCE, Inc. announced their intention to merge last month. The combined company will be called Inform DX, Inc. and will compete nationally for anatomic pathol…
1-For-10 Reverse Stock Split Boosts LabCorp’s Share Price
By Robert Michel | From the Volume VII No. 9 – June 19, 2000 Issue
MAY PROVED TO BE an auspicious time for Laboratory Corporation of America to restructure its equity base. In the process, it’s positioning itself to be a tougher competitor in the lab testing marketplace. Ever since the company was first created by the merger of Roche Biom…
Questions Remain About Performance Of Liquid-Prep Paps
By Robert Michel | From the Volume VII No. 9 – June 19, 2000 Issue
CEO SUMMARY: During the past five years, several companies entered the lab marketplace with claims that their new Pap test technologies are improvements over conventional Pap smear methods. Armed with investment capital from Wall Street, these companies launched aggressive sales and marke…
ProxyMed, MedePass, Cigna, Aetna
By Robert Michel | From the Volume VII No. 9 – June 19, 2000 Issue
FORMER SBCL PRESIDENT HAS QUICK TOUR AS CEO OF PROXYMED, INC. IT WAS A SHORT TOUR OF DUTY as Chief Executive Officer at ProxyMed, Inc. for John B. Okkerse, Jr., Ph.D. On May 19, after only six months as ProxyMed’s CEO, Dr. Okkerse stepped down as part of a cost-cutting mo…
BRLI Ready To Leverage Physician Relationship
By Robert Michel | From the Volume VII No. 8 – May 30, 2000 Issue
CEO SUMMARY: As healthcare E-commerce rapidly approaches, clinical laboratories will find they have a built-in competitive advantage—their existing business relationship and communication links to physician offices. Bio-Reference Laboratories, Inc. is moving rapidly to capitalize on thi…
New CEO Takes Charge At Pathology Partners
By Robert Michel | From the Volume VII No. 8 – May 30, 2000 Issue
CEO SUMMARY: Pathology Partners, Inc. got a new President and CEO this month. The company is organized to build and operate independent regional histology and cytology laboratories in support of anatomic pathologists. Its business model is different than competing pathology companies and …
War College Identifies Emerging Lab Trends
By Robert Michel | From the Volume VII No. 8 – May 30, 2000 Issue
CEO SUMMARY: Disruptive technologies and the arrival of healthcare E-commerce were two common themes which emerged from this year’s Executive War College on Laboratory and Pathology Management. Consensus by faculty and attendees alike was that every lab organization should have an Inter…
CURRENT ISSUE

Volume XXXII, No. 10 – July 14, 2025
This issue is strong on different flavors of enforcement that clinical laboratories, whether they want to or not, will need to contend with. Lab stakeholders provide insights that medical labs need to brace for more action to counter pending test reimbursement rate cuts under PAMA. Also, this issue provides the legal and regulatory landscape for clinical labs’ use of AI and how it evolves with the technology. AI is creating legal uncertainty for clinical labs, especially around data privacy and FDA oversight of AI tools in diagnostics.
See the full table of contentsHow Much Laboratory Business Intelligence Have You Missed?
Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!
Sign up for TDR Insider
Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.
Topics
- Anatomic Pathology
- Clinical Chemistry
- Clinical Laboratory
- Clinical Laboratory Trends
- Digital Pathology
- Genetic Testing
- In Vitro Diagnostics
- IVD/Lab Informatics
- Lab Intelligence
- Lab Marketplace
- Lab Risk & Compliance
- Laboratory Automation
- Laboratory Billing
- Laboratory Compliance
- Laboratory Equipment
- Laboratory Information Systems
- Laboratory Management
- Lean Six Sigma
- Managed Care Contracts
- Molecular Diagnostics
- Pathology Trends
- People
- Uncategorized